His monographs include Callous Objects: Designs Against the Homeless, and Distracted: A Philosophy of Cars and Phones which recently received The Dorothy Lee Award for Outstanding Scholarship in the Ecology of Culture from the Media Ecology Association
A.VaqueroC.LoiraI.CuerdaR.PalomeroF.et al
The most widely used GLP-1 RAs today and those currently attributed with the most clinical evidence in weight management include Liraglutide, Semaglutide, and Tirzepatide (as a dual agonist of GLP-1 and glucose-dependent insulinotropic polypeptide) [25]
Clinical trial results suggest that tirzepatide outperforms semaglutide, a sole GLP-1 receptor agonist, for controlling blood sugar and reducing weight
Contrary to the R -gene mediated HR-type cell death, recognition in the case of basal resistance is unspecific, as intruders are recognized based on their common molecular patterns
Adverse Reactions Occurring at an Incidence of 2% or More Among VYVANSE Treated Patients with ADHD in Clinical Trials Adverse reactions reported in the controlled trials in pediatric patients ages, 6 to 12 years (Study 1), pediatric patients ages 13 to 17 years (Study 4), and adult patients (Study 7) treated with VYVANSE or placebo are presented in Tables 1, 2 and 3 below